Targeted therapies in the management of advanced medullary thyroid cancer
Targeted therapies have reshaped the management of advanced MTC, with selective RET inhibitors offering improved efficacy and tolerability, and continued research is essential to overcome resistance, expand therapeutic options, and improve patient outcomes.